Insider: MAZELSKY JONATHAN JAY President and CEO - IDEXX LABORATORIES INC /DE
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 102,887 | 0 | 102,887 |
| Value | $58,599,462.85 | $0.00 | $58,599,462.85 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/26/2026 | DDS | 1,669 | Direct | COM | $652.49 | $1,089,013.32 | 102,887 |
| 02/26/2026 | DDS | 1,171 | Direct | COM | $653.68 | $765,454.95 | 101,716 |
| 02/26/2026 | DDS | 1,095 | Direct | COM | $651.49 | $713,377.83 | 104,556 |
| 02/26/2026 | DDS | 1,281 | Direct | COM | $650.67 | $833,507.63 | 105,651 |
| 02/26/2026 | DDS | 2,589 | Direct | COM | $663.04 | $1,716,620.66 | 83,606 |
| 02/26/2026 | DDS | 1,488 | Direct | COM | $655.85 | $975,904.50 | 99,117 |
| 02/26/2026 | DDS | 1,111 | Direct | COM | $654.63 | $727,293.26 | 100,605 |
| 02/26/2026 | DDS | 1,200 | Direct | COM | $661.10 | $793,317.12 | 87,195 |
| 02/26/2026 | DDS | 1,000 | Direct | COM | $662.16 | $662,156.70 | 86,195 |
| 02/26/2026 | DDS | 1,343 | Direct | COM | $656.85 | $882,142.97 | 97,774 |
| 02/26/2026 | DDS | 2,859 | Direct | COM | $659.75 | $1,886,223.82 | 88,395 |
| 02/26/2026 | DDS | 3,660 | Direct | COM | $658.92 | $2,411,634.76 | 91,254 |
| 02/26/2026 | DDS | 2,860 | Direct | COM | $657.84 | $1,881,433.27 | 94,914 |
| 08/06/2025 | DDS | 3,397 | Direct | COM | $629.82 | $2,139,508.05 | 106,554 |
| 08/06/2025 | DDS | 1,525 | Direct | COM | $628.27 | $958,114.80 | 109,951 |
| 08/06/2025 | DDS | 6,056 | Direct | COM | $630.59 | $3,818,874.24 | 100,498 |
| 08/06/2025 | DDS | 1,095 | Direct | COM | $626.90 | $686,458.13 | 111,476 |
| 08/06/2025 | DDS | 7,299 | Direct | COM | $631.61 | $4,610,095.84 | 93,199 |
| 08/06/2025 | DDS | 660 | Direct | COM | $639.37 | $421,985.39 | 83,311 |
| 08/06/2025 | DDS | 880 | Direct | COM | $636.81 | $560,391.30 | 83,971 |
| 08/06/2025 | DDS | 1,822 | Direct | COM | $636.15 | $1,159,068.40 | 84,851 |
| 08/06/2025 | DDS | 3,000 | Direct | COM | $632.56 | $1,897,689.00 | 90,199 |
| 08/06/2025 | DDS | 3,526 | Direct | COM | $635.13 | $2,239,457.10 | 86,673 |
| 02/07/2024 | DDS | 4,124 | Direct | COM | $572.53 | $2,361,094.34 | 81,767 |
| 02/07/2024 | DDS | 462 | Direct | COM | $573.19 | $264,814.29 | 81,305 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research